Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsRare Diseases
This learning journey aims to provide an introduction to rare diseases and their underlying mechanisms. It delves into a few illustrative examples and emphasizes the significance of biobanks. Moreover, it covers the process of designing cohort studies and clinical trials tailored for rare diseases.
Table of Contents
- What are rare diseases?
- Mechanisms of rare diseases
- Inheritance of rare mitochondrial diseases
- Example: Red blood cell and rare anaemias
- Example: Lysosomal storage diseases
- Role of biobanks in rare diseases
- Cohort study design and rare diseases
- Clinical trial designs for rare diseases
- Key considerations for clinical trials on rare diseases
1. What are rare diseases?
By Dr. Anne Pariser – National Institutes of Health, USA
An excerpt from Clinical trial designs for rare diseases 1: trial designs
-
Play What are rare diseases?
2. Mechanisms of rare diseases
By Prof. Eamonn Maher – University of Cambridge, UK
An excerpt from Mechanisms of human genetic disease
-
Play Mechanisms of rare diseases
3. Inheritance of rare mitochondrial diseases
By Prof. Eamonn Maher – University of Cambridge, UK
An excerpt from Mitochondria in health and disease
-
Play Inheritance of rare mitochondrial diseases
4. Example: Red blood cell and rare anaemias
By Prof. Emeritus Joan-Lluis Vives Corrons – Josep Carreras Leukaemia Research Institute, Spain
An excerpt from Diagnosis and management of hereditary spherocytosis and elliptocytosis
-
Play Example: Red blood cell and rare anaemias
5. Example: Lysosomal storage diseases
By Prof. Fran Platt – University of Oxford, UK
An excerpt from Lysosomal storage diseases
-
Play Example: Lysosomal storage diseases
6. Role of biobanks in rare diseases
By Dr. Elvira Mambetisaeva – University College London, UK
An excerpt from Biobanks and their role in biomedical research
-
Play Role of biobanks in rare diseases
7. Cohort study design and rare diseases
By Dr. Rana Ismail – Michigan State University, USA
An excerpt from Overview on cohort study design
-
Play Cohort study design and rare diseases
8. Clinical trial designs for rare diseases
By Dr. Anne Pariser – National Institutes of Health, USA
An excerpt from Clinical trial designs for rare diseases 1: trial designs
-
Play Clinical trial designs for rare diseases
9. Key considerations for clinical trials on rare diseases
By Dr. Anne Pariser – National Institutes of Health, USA
An excerpt from Clinical trial designs for rare diseases 2: trial protocols
-
Play Key considerations for clinical trials on rare diseases